Rigel Pharmaceuticals Inc (NASDAQ:RIGL)

1.54
Delayed Data
As of Aug 12
 +0.14 / +10.00%
Today’s Change
0.64
Today|||52-Week Range
4.24
-41.89%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues4.9M37.9M12.6M10.4M
 
 
 
 
 
Cost of Goods Sold69.0K25.0K25.0K138.0K
 
 
 
 
 
Depreciation And Amortization159.0K163.0K164.0K173.0K
 
 
 
 
 
 
Operating ExpensesGross Income4.6M37.7M12.4M10.1M
 
 
 
 
 
General Expenses29.0M35.1M30.8M31.4M
 
 
 
 
 
Research And Development11.1M13.8M10.9M13.2M
 
 
 
 
 
Total Operating Expenses29.2M35.3M31.0M31.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-24.4M2.5M-18.4M-21.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-23.8M3.2M-17.6M-20.6M
 
 
 
 
 
Net Income-23.8M3.2M-17.6M-20.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS166.5M166.7M167.2M167.2M
 
 
 
 
 
Shares To Calculate EPS Diluted166.5M167.6M167.2M167.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.14$0.02-$0.11-$0.12
 
 
 
 
 
EPS Diluted-$0.14$0.02-$0.11-$0.12